Send Inquiry

Request To Call Back

100mg Bevacizumab Injection

Get a Price/Quote

MOQ : 100 Packs

100mg Bevacizumab Injection Specification

Origin of Medicine
Allopathic

Dosage Form
Injection

Packaging Type
Glass Vial

Salt Composition
Bevacizumab

Brand Name
Bevacizumab Injection

Indication
Metastatic cancer treatment, Macular degeneration, Recurrent Glioblastoma

Pacakaging (Quantity Per Box)
1 Vial per box

Life Span
24 Months from manufacturing date

Drug Type
Prescription Drug

Ingredients
Bevacizumab 100mg

Physical Form
Liquid Injection

Function
Antineoplastic (anticancer) agent, Inhibits angiogenesis

Recommended For
Cancer Patients (Colorectal, Lung, Renal Cell Carcinoma, Glioblastoma, Cervical and Ovarian Cancer)

Dosage
As directed by physician, typically 5-15 mg/kg every 2-3 weeks

Dosage Guidelines
Administered by IV infusion under supervision

Suitable For
Adults

Quantity
4 ml Vial

Storage Instructions
Store between 2C to 8C, Do not freeze

Appearance
Clear to slightly opalescent, colorless to pale brownish-yellow solution

Warning
Use only under medical supervision, not for use in pregnancy or breastfeeding unless advised

Side Effects
Proteinuria, hypertension, bleeding, GI perforations (see physician for full profile)

Shelf Life after Opening
Use immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.

Contraindications
Known hypersensitivity to Bevacizumab or any excipients

Route of Administration
Parenteral

ATC Code
L01XC07

Preservative
Preservative free

Therapeutic Class
Monoclonal Antibody (Anti-VEGF)

Market Authorization Holder
As per regulatory approval

Concentration
25 mg/ml

Method of Administration
Intravenous use only (IV infusion)

100mg Bevacizumab Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

100mg Bevacizumab Injection About

Jump on this preeminent offer with a remarkable Price Cut on 100mg Bevacizumab Injection, favorably reviewed for its sublime efficacy. This uncommon monoclonal antibody (Anti-VEGF), ATC Code L01XC07, is indicated for metastatic cancer treatment-including colorectal, lung, renal cell carcinoma, glioblastoma, cervical, and ovarian cancer. Administered intravenously, the clear to slightly opalescent liquid delivers precise dosing (5-15 mg/kg every 2-3 weeks) under medical supervision. Suitable for adults, preservative-free, and shelf-stable for 24 months, it is trusted for its antineoplastic action and proven performance.

Method of Administration and Expanded Applications

100mg Bevacizumab Injection is administered via intravenous infusion, ensuring direct and effective delivery to the bloodstream. While primarily indicated for metastatic cancers such as colorectal, lung, and ovarian, its application has been extended to conditions like macular degeneration and recurrent glioblastoma. Distinct features include a preservative-free, colorless to pale brownish-yellow, clear solution, housed in a robust 4 ml glass vial. This thoughtful design makes it ideal for precise dosing and ensures product integrity throughout its lifespan.

Sample Availability, Port, and Payment Solutions

Samples of the 100mg Bevacizumab Injection are available for evaluation, with supplies handed over efficiently through reliable distribution from our designated FOB port in India. Flexible payment terms can be discussed to suit your proposal amount, ensuring a seamless transaction experience. Our commitment is reflected in streamlined processes, from sample requests to finalized orders, providing robust support and prompt supply to meet medical requirements. Request your sample and secure your needed stock through straightforward commercial arrangements.

FAQ's of 100mg Bevacizumab Injection:

Q: How is 100mg Bevacizumab Injection administered?

A: The injection is administered intravenously (IV infusion) by a trained healthcare professional, ensuring the medication is delivered directly into the bloodstream for optimal therapeutic effects.

Q: What conditions can Bevacizumab Injection be used to treat?

A: Bevacizumab Injection is indicated for the treatment of metastatic cancers such as colorectal, lung, renal cell carcinoma, glioblastoma, cervical, and ovarian cancer. It is also used for macular degeneration and recurrent glioblastoma.

Q: When should Bevacizumab Injection not be used?

A: It should not be used in patients with known hypersensitivity to Bevacizumab or any of its excipients. It is also not recommended during pregnancy or breastfeeding, unless specifically advised by a physician.

Q: Where should Bevacizumab Injection be stored?

A: The injection must be stored between 2C to 8C and should never be frozen. Proper refrigeration preserves product efficacy and safety until administration.

Q: What is the process for obtaining a sample or placing an order?

A: Contact us with your requirements. After discussing the proposal amount and supply needs, samples can be handed over at the designated FOB port, with flexible payment terms arranged to facilitate your acquisition.

Q: How does Bevacizumab Injection benefit cancer patients?

A: Bevacizumab works as an antineoplastic agent inhibiting angiogenesis, blocking the formation of new blood vessels that tumors need for growth, thereby restricting cancer progression under expert medical supervision.

Tell us about your requirement